FI120346B - Sientenvastainen yhdiste, sitä sisältävä koostumus ja sen käyttö - Google Patents

Sientenvastainen yhdiste, sitä sisältävä koostumus ja sen käyttö Download PDF

Info

Publication number
FI120346B
FI120346B FI950514A FI950514A FI120346B FI 120346 B FI120346 B FI 120346B FI 950514 A FI950514 A FI 950514A FI 950514 A FI950514 A FI 950514A FI 120346 B FI120346 B FI 120346B
Authority
FI
Finland
Prior art keywords
added
compound
solution
mixture
resulting
Prior art date
Application number
FI950514A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI950514A (fi
FI950514A0 (fi
Inventor
Toshihiko Naito
Akihiko Tsuruoka
Kazumasa Nara
Itaru Tsukada
Katsura Hata
Yumiko Kaku
Manabu Yanagisawa
Toshio Toyosawa
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP03326894A external-priority patent/JP3691856B2/ja
Priority claimed from JP17489494A external-priority patent/JP3452213B2/ja
Priority claimed from JP20820394A external-priority patent/JP3635686B2/ja
Priority claimed from JP6306467A external-priority patent/JPH08165263A/ja
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of FI950514A0 publication Critical patent/FI950514A0/fi
Publication of FI950514A publication Critical patent/FI950514A/fi
Application granted granted Critical
Publication of FI120346B publication Critical patent/FI120346B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/176—Unsaturated ethers containing halogen containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1786—Unsaturated ethers containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI950514A 1994-02-07 1995-02-06 Sientenvastainen yhdiste, sitä sisältävä koostumus ja sen käyttö FI120346B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP3326894 1994-02-07
JP03326894A JP3691856B2 (ja) 1994-02-07 1994-02-07 抗真菌剤及びその製法
JP17489494 1994-07-05
JP17489494A JP3452213B2 (ja) 1994-07-05 1994-07-05 抗真菌剤及びその製造方法
JP20820394 1994-08-10
JP20820394A JP3635686B2 (ja) 1994-08-10 1994-08-10 抗真菌剤及びその製造方法
JP6306467A JPH08165263A (ja) 1994-12-09 1994-12-09 抗真菌剤の製造方法および中間体
JP30646794 1994-12-09

Publications (3)

Publication Number Publication Date
FI950514A0 FI950514A0 (fi) 1995-02-06
FI950514A FI950514A (fi) 1995-08-08
FI120346B true FI120346B (fi) 2009-09-30

Family

ID=27459765

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950514A FI120346B (fi) 1994-02-07 1995-02-06 Sientenvastainen yhdiste, sitä sisältävä koostumus ja sen käyttö

Country Status (13)

Country Link
US (3) US5648372A (ru)
EP (4) EP0667346A3 (ru)
KR (2) KR100383369B1 (ru)
CN (5) CN1478778A (ru)
AU (1) AU696640B2 (ru)
CA (1) CA2141731C (ru)
FI (1) FI120346B (ru)
HK (1) HK1040711A1 (ru)
HU (3) HU228059B1 (ru)
NO (6) NO304430B1 (ru)
NZ (1) NZ270418A (ru)
RU (1) RU2142947C1 (ru)
TW (1) TW416955B (ru)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
CA2180091A1 (en) * 1995-07-08 1997-01-09 Hiroki Kodama Optically active triazole derivative, process for producing the same, antifungal agent, and method for using the same
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
NZ328607A (en) * 1996-09-09 1999-08-30 Hoffmann La Roche Heterocyclically substituted n-benzyl-azolium derivatives and fungicidal compositions
EP0829478A3 (en) * 1996-09-09 1998-03-25 F. Hoffmann-La Roche Ag N-Benzylimidazolium and N-benzyltriazolium derivatives, their preparation and their use as antifungal and antimycotic agents
DE19751525C2 (de) 1997-11-20 2003-02-13 Bat Cigarettenfab Gmbh Verfahren und Vorrichtung zur Regelung der Ausgangsfeuchte von Tabak
IT1296925B1 (it) 1997-12-05 1999-08-03 Zambon Spa Procedimento per la preparazione di composti ad attivita' antimicotica
AU2931399A (en) * 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
US6265584B1 (en) 1998-05-22 2001-07-24 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
AU1915500A (en) 1998-11-20 2000-06-13 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6235728B1 (en) 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
US6326509B1 (en) 1999-05-20 2001-12-04 Bristol-Myers Squibb Company Process for azole antifungal intermediate
US6812238B1 (en) 1999-11-02 2004-11-02 Basilea Pharmaceutica Ag N-substituted carbamoyloxyalkyl-azolium derivatives
US6362172B2 (en) 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6319933B1 (en) 2000-04-17 2001-11-20 Basilea Pharmaceutica Ag Azole derivatives
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
US6969730B2 (en) * 2001-03-16 2005-11-29 Abbott Laboratories Amines as histamine-3 receptor ligands and their therapeutic applications
JP4125672B2 (ja) 2001-06-26 2008-07-30 バジリア ファルマスーチカ アーゲー アゾール誘導体製造方法における中間体ハロフェニル誘導体およびそれらの使用
EP1474132A1 (en) * 2002-01-11 2004-11-10 Abbott Laboratories Histamine-3 receptor ligands for diabetic conditions
CN1630646A (zh) * 2002-02-15 2005-06-22 三井化学株式会社 旋光性吡咯衍生物及其制造方法
US7812045B2 (en) * 2005-03-30 2010-10-12 Daewoong Pharmaceutical Co., Ltd. Antifungal triazole derivatives
JO2691B1 (en) * 2005-05-03 2013-03-03 ايساي آر آند دي مانجمنت كو.، ليمتد Monolysine salts for azole compounds
KR20080062876A (ko) * 2006-12-29 2008-07-03 주식회사 대웅제약 신규한 항진균성 트리아졸 유도체
WO2008103500A1 (en) * 2007-02-22 2008-08-28 Irm Llc Thiazole derivatives as modulators of g protein-coupled receptors
US20100094001A1 (en) 2007-03-06 2010-04-15 Eisai R&D Management Co., Ltd. Composition containing stability-improved chloromethyl phosphate derivative and process for producing same
WO2009024590A2 (en) 2007-08-21 2009-02-26 Basilea Pharmaceutica Ag Antifungal composition
JP2011516613A (ja) * 2008-04-15 2011-05-26 シェーリング コーポレイション 好ましくはポサコナゾールおよびｈｐｍｃａｓを含む固体分散物中の経口用薬学的組成物
EP2285351A2 (en) * 2008-04-15 2011-02-23 Schering Corporation Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
US8207352B2 (en) * 2009-10-08 2012-06-26 Drug Process Licensing Associates LLC Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole
EP2571847B1 (en) 2010-05-19 2016-09-21 Sandoz AG Process for the preparation of chiral hydrazides
RU2580318C2 (ru) * 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
RU2585683C2 (ru) * 2010-05-19 2016-06-10 Сандоз Аг Очистка позаконазола и промежуточных продуктов для синтеза позаконазола
BR112012030186B1 (pt) 2010-05-27 2017-12-19 Bayer Intellectual Property Gmbh Alcanol heterocyclic derivatives, its uses, a composition and its preparation process, and a process for combating phytopathogenic harmful fungi
CA2838051C (en) 2011-06-16 2019-09-24 Sandoz Ag Process for the preparation of a chiral compound
CN102503901B (zh) * 2011-10-27 2014-06-18 中国人民解放军南京军区联勤部药品仪器检验所 氮唑类抗真菌化合物及其制备方法和应用
CN102796080B (zh) * 2012-05-16 2016-04-06 中国人民解放军第二军医大学 一种新型氮唑类抗真菌化合物及其制备方法和应用
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
WO2016055918A1 (en) 2014-10-08 2016-04-14 Wockhardt Limited Novel stable polymorphs of isavuconazole or its salt thereof
CA2910990C (en) 2014-11-23 2022-03-22 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of efinaconazole
WO2017020944A1 (en) * 2015-07-31 2017-02-09 Universite De Nantes Novel fused pyrimidinone and triazinone derivatives, their process of preparation and their therapeutic uses as antifungal and/or antiparasitic agents
CN106588955B (zh) * 2015-10-14 2020-08-18 西南大学 咪唑并苯并噻唑衍生的氟康唑类似物及其制备方法和应用
CN106957306A (zh) * 2016-01-11 2017-07-18 武汉诺安药业有限公司 一种艾氟康唑中间体的合成方法
CN107602547A (zh) * 2017-09-28 2018-01-19 南开大学 一类杂环三唑衍生物及其制备方法和用途
CN110498774A (zh) * 2018-05-18 2019-11-26 上海医药工业研究院 一种艾沙康唑中间体的制备方法
CN113710248A (zh) * 2019-04-08 2021-11-26 株式会社赛轮制药 抗真菌剂
CN110885323A (zh) * 2019-12-02 2020-03-17 中国人民解放军第二军医大学 一种三氮唑醇类衍生物、其制备方法及应用
WO2021245590A1 (en) * 2020-06-04 2021-12-09 Metrochem Api Private Limited An improved process for the preparation of triazole derivatives

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US495049A (en) * 1893-04-11 Propagating-box
US2587210A (en) * 1949-08-01 1952-02-26 Union Carbide & Carbon Corp Production of acrylamides
US4191842A (en) * 1975-01-27 1980-03-04 Hoffmann-La Roche Inc. Protected alcohols
EG12446A (en) * 1975-05-23 1979-06-30 Shell Int Research 2-substituted isovalerates compounds
JPS52286A (en) * 1975-05-27 1977-01-05 Kyorin Pharmaceut Co Ltd Method of preparing 1-(3-phenylpropyl)-4-acylpiperazine derivatives
US4115578A (en) * 1975-12-18 1978-09-19 Rohm And Haas Company 1-Substituted aralkyl imidazoles
DE2623129C3 (de) 1976-05-22 1980-04-10 Nordmark-Werke Gmbh, 2000 Hamburg U-Diphenyl-3-(imidazol-l-yl) -propan-2-ole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4654332A (en) * 1979-03-07 1987-03-31 Imperial Chemical Industries Plc Heterocyclic compounds
GB2078719B (en) 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
DE3177275D1 (de) 1980-08-18 1992-04-16 Ici Plc Verwendung von triazolylaethanol-derivate und deren zusammensetzungen als nichtlandwirtschaftliche fungizide.
EP0046337A3 (en) * 1980-08-20 1982-09-15 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant and pharmaceutical fungicides and as plant growth regulators and compositions containing them
DE3262386D1 (en) 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
ES523184A0 (es) * 1982-06-17 1985-04-01 Pfizer Un procedimiento para la preparacion de un compuesto dotado de propiedades fungicidas
DE3237400A1 (de) * 1982-10-08 1984-04-12 Bayer Ag, 5090 Leverkusen Substituierte 1-hydroxyethyl-triazolyl-derivate
GB8301699D0 (en) * 1983-01-21 1983-02-23 Pfizer Ltd Antifungal agents
EP0117578A3 (en) * 1983-02-23 1985-01-30 Shionogi & Co., Ltd. Azole-substituted alcohol derivatives
DE3307218A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte diazolylalkyl-carbinole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
GB8306351D0 (en) * 1983-03-08 1983-04-13 Ici Plc Azole fungicides
DK159205C (da) * 1983-03-16 1991-03-04 Pfizer Bis(triazol)alkanol-forbindelser, anvendelse af disse, farmaceutiske praeparater og landbrugsfungicider indeholdende disse og fremgangsmaade til behandling af planter eller froe, som har en svampeinfektion
GB8313235D0 (en) 1983-05-13 1983-06-22 Pfizer Ltd Antifungal agents
DE3484968D1 (de) 1983-05-19 1991-10-02 Ciba Geigy Ag Verfahren zur herstellung von 1-triazolylethylether-derivaten, sowie mikrobizide mittel enthaltende neue 1-triazolyl-phenoxyphenylethylether-derivate als wirkstoffe und deren verwendung.
DE3325313A1 (de) * 1983-07-13 1985-01-31 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung
JPS6069067A (ja) * 1983-09-26 1985-04-19 Sumitomo Chem Co Ltd フェニルプロピルアゾ−ル，その製造法およびそれを有効成分とする植物病害防除剤
DE3342693A1 (de) 1983-11-25 1985-06-05 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von ss-hydroxy-ethyl-(1,2,4-triazol)- derivaten
DE3478744D1 (en) * 1983-12-08 1989-07-27 Ciba Geigy Ag 1-di- or triazolyl-2,3-diphenyl-propane-2,3-dioles as herbicides or plant growth regulators
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
DE3413173A1 (de) * 1984-04-07 1985-10-17 Bayer Ag, 5090 Leverkusen (1,2,4-triazol-1-yl)-methyl-carbinole
AU4327585A (en) 1984-06-21 1986-01-02 Imperial Chemical Industries Plc Antifungal azole compounds
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
JPS6345277A (ja) * 1986-04-03 1988-02-26 Shionogi & Co Ltd イソオキサゾリルエタノ−ル誘導体、抗真菌剤および農業用殺菌剤
DE3703082A1 (de) 1987-02-03 1988-08-11 Bayer Ag Verfahren zur herstellung optisch aktiver 2-hydroxyethyl-azol-derivate
DE3813841A1 (de) * 1987-06-03 1988-12-15 Bayer Ag Heterocyclische hydroxyethylazole
DE3852344T2 (de) * 1987-06-16 1995-05-18 Du Pont Verfahren zur Isomerierung von symmetrischen Triazolen zu unsymmetrischen Triazolen.
GB8716651D0 (en) 1987-07-15 1987-08-19 Ici Plc 2-propanol derivatives
DE3830240A1 (de) * 1987-10-14 1989-04-27 Bayer Ag Substituierte 1-aryl-1-(thiazol-2-yl)-2-(1,2,4-triazol-1-yl)- und -(imidazol-1-yl)-ethanole, verfahren sowie substituierte 1-aryl-1-(thiazol-2-yl)-2-bromethanole als zwischenprodukte zu ihrer herstellung, und sie enthaltende fungizide und pflanzenwuchsregulierende mittel
DE3736783A1 (de) * 1987-10-30 1989-05-11 Bayer Ag Verwendung neuer azolylmethylcarbinole zur behandlung von krankheiten
IT1232943B (it) * 1987-11-09 1992-03-10 Mini Ricerca Scient Tecnolog Azolilderivati fungicidi.
EP0440608A1 (en) 1987-12-17 1991-08-14 E.I. Du Pont De Nemours And Company Antifungal carbinols
HUT53889A (en) * 1988-03-04 1990-12-28 Sankyo Co. Ltd.,Jp Fungicides comprising triazole derivatives as active ingredient and process for producing the active ingredient
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
IE903395A1 (en) * 1989-09-26 1991-04-10 Takeda Chemical Industries Ltd Triazole compounds, their production and use
US5134152A (en) * 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
US5049570A (en) * 1990-01-23 1991-09-17 Du Pont Merck Pharmaceutical Company Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
TW211006B (ru) * 1990-08-24 1993-08-11 Mochida Pharm Co Ltd
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
EP0548553A1 (en) * 1991-11-25 1993-06-30 Takeda Chemical Industries, Ltd. Optically active azole compounds, their production and use
TW218017B (ru) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
JPH069624A (ja) * 1992-06-24 1994-01-18 Ikeda Mohandou:Kk トリアゾール誘導体
GB9317491D0 (en) 1993-08-23 1993-10-06 Fujisawa Pharmaceutical Co New compound and a process for preparation thereof
IL105200A (en) 1993-03-29 1997-03-18 Teva Pharma Regiospecific processes for the preparation of 1, 3-bis (1, 2, 4-triazol-1-yl)-propan- 2-ol derivatives
TW297813B (ru) * 1993-09-24 1997-02-11 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
NO975775L (no) 1997-12-08
EP0667346A3 (en) 1998-04-29
US5792781A (en) 1998-08-11
HU0301171D0 (en) 2003-07-28
CN1121404C (zh) 2003-09-17
NO975775D0 (no) 1997-12-08
NO20022266D0 (no) 2002-05-13
US5789429A (en) 1998-08-04
CN1188765A (zh) 1998-07-29
HU227492B1 (en) 2011-07-28
HU0204488D0 (en) 2003-02-28
AU696640B2 (en) 1998-09-17
KR950032186A (ko) 1995-12-20
RU2142947C1 (ru) 1999-12-20
HU228059B1 (en) 2012-09-28
RU95101828A (ru) 1996-12-27
NO319229B1 (no) 2005-07-04
NO975774L (no) 1997-12-08
FI950514A (fi) 1995-08-08
KR100383369B1 (ko) 2003-09-13
US5648372A (en) 1997-07-15
CN1113241A (zh) 1995-12-13
CA2141731C (en) 2009-09-08
NO306301B1 (no) 1999-10-18
HK1040711A1 (zh) 2002-06-21
NZ270418A (en) 1997-09-22
CN1045441C (zh) 1999-10-06
EP1394142A1 (en) 2004-03-03
CN1219538A (zh) 1999-06-16
CN1061347C (zh) 2001-01-31
NO304430B1 (no) 1998-12-14
NO950425L (no) 1995-08-08
NO305319B1 (no) 1999-05-10
EP1231210A3 (en) 2002-12-04
HU227239B1 (en) 2010-12-28
CA2141731A1 (en) 1995-08-08
NO20022266L (no) 1995-08-08
TW416955B (en) 2001-01-01
NO314998B1 (no) 2003-06-23
CN1478778A (zh) 2004-03-03
EP1231210A2 (en) 2002-08-14
EP1394162A1 (en) 2004-03-03
HU9500354D0 (en) 1995-03-28
NO950425D0 (no) 1995-02-06
HUT74098A (en) 1996-11-28
CN1134421C (zh) 2004-01-14
NO991165L (no) 1995-08-08
KR100451067B1 (ko) 2004-10-02
EP0667346A2 (en) 1995-08-16
FI950514A0 (fi) 1995-02-06
CN1320597A (zh) 2001-11-07
NO20034737L (no) 1995-08-08
NO20034737D0 (no) 2003-10-23
NO975774D0 (no) 1997-12-08
NO991165D0 (no) 1999-03-10
AU1155695A (en) 1995-08-17

Similar Documents

Publication Publication Date Title
FI120346B (fi) Sientenvastainen yhdiste, sitä sisältävä koostumus ja sen käyttö
US4156008A (en) 1-(4-Alkyl-2-aryl-1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US9416140B2 (en) Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof
JP2997947B2 (ja) トリアゾール化合物およびその用途
RU2642065C2 (ru) Производные 1-(4,5-дигидроимидазол)-изохромана или 1-(4,5-дигидро)-изотиохромана, полезные в качестве агонистов альфа2 адренорецепторов
KR900003302B1 (ko) 하이드록시알킬-아졸릴 유도체의 제조방법
CN104774195A (zh) 一种光学纯伊曲康唑关键中间体及合成方法以及由该中间体合成光学纯伊曲康唑的方法
JPS6135196B2 (ru)
JP2650651B2 (ja) シクロヘキサン誘導体
Sasaki et al. Determination of the absolute structure of (+)-cystothiazole B
US20130211103A1 (en) Intermediates and methods for making zearalenone macrolide analogs
US9957279B2 (en) Process for the preparation of intermediates useful in the preparation of Hepatitis C virus (HCV) inhibitors
EP1475370A1 (en) Optically active azole derivative and process for producing the same
CA1242732A (en) Leukotriene antagonists
KR102597119B1 (ko) 에피나코나졸의 제조 및 정제 방법
US5719291A (en) Cyclohexane derivatives
KR950005741B1 (ko) 항균 활성을 제공하는 아졸릴-유도체의 제조방법
EP0421600A1 (en) Asymmetric chemical synthesis and intermediates for making antifungal compounds
AU717799B2 (en) Antifungal agents, processes for the preparation thereof, and intermediates
JP2004131462A (ja) 光学活性アゾール誘導体およびその製造法
Kawada et al. Full Text HTML
JPH08165263A (ja) 抗真菌剤の製造方法および中間体
EP2222680A1 (en) Process improvement
RO120339B1 (ro) Procedeu de preparare a recemicului 2-etil-1, 6-dioxaspiro[4,4]nonanului, feromon de agregare al gândacului de scoarţă - pytiogenes chalcographus (coleoptere, scolitidae)
NZ314252A (en) Precursor compounds, eg protected 3-phenylalkanol derivatives

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: EISAI R&D MANAGEMENT CO. LTD.

Free format text: EISAI R&D MANAGEMENT CO. LTD.

FG Patent granted

Ref document number: 120346

Country of ref document: FI

MM Patent lapsed